Skip to main content
Erschienen in: Clinical and Experimental Nephrology 2/2018

01.02.2018 | Special report

Essentials from clinical practice guidelines for CKD stage G3b-5 2017

verfasst von: Hirokazu Okada, Research Team for a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Diseases from Japan Agency for Medical Research and Development, AMED

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

1.
High: We are confident that the true effect lies close to that of the estimate of the effect.
 
2.
Moderate: The true effect is likely to be close to the estimation of the effect, but there is a possibility that it is substantially different.
 
3.
Low: The true effect may be substantially different from the estimation of the effect.
 
4.
Very low: The estimation of the effect is very uncertain, and will often be far from the truth.
 
Metadaten
Titel
Essentials from clinical practice guidelines for CKD stage G3b-5 2017
verfasst von
Hirokazu Okada
Research Team for a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J)
Practical Research Project for Renal Diseases from Japan Agency for Medical Research and Development, AMED
Publikationsdatum
01.02.2018
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 2/2018
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1532-z

Weitere Artikel der Ausgabe 2/2018

Clinical and Experimental Nephrology 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.